SGMT

NASDAQ · Biotechnology

Sagimet Biosciences Inc-A

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.60

-0.05 (-0.65%)

As of May 16, 2:07 AM ET ·

SGMT News1 articles

Sagimet Biosciences Soars After $175M Stock Sale to Fund Acne Drug Trial

Sagimet Biosciences shares surged 38% after announcing a $175 million stock offering to fund a Phase 3 acne trial for denifanstat, with proceeds expected to support dermatology programs through 2028.